Biomarkers for the development of cancer vaccines: current status.

@article{Copier2006BiomarkersFT,
  title={Biomarkers for the development of cancer vaccines: current status.},
  author={John P. Copier and Mike Whelan and Angus Dalgleish},
  journal={Molecular diagnosis & therapy},
  year={2006},
  volume={10 6},
  pages={337-43}
}
Significant improvements in our knowledge of tumor immunology have resulted in more sophisticated vaccine approaches for the treatment of cancer. However, research into biomarkers that correlate with the clinical outcome of immunotherapy has lagged behind vaccine development. To this extent, very few immunological or other markers exist that can be used in… CONTINUE READING